Home/ Stocks/ TCRT

Alaunos Therapeutics, Inc. Common Stock

TCRT XNAS

$1.99 +0.00 (+0.00%) ▲ 15-min delayed

Open

$1.97

High

$2.00

Low

$1.95

Volume

6.1K

Market Cap

$4.86M

About Alaunos Therapeutics, Inc. Common Stock

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 1 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-1,006,000	$-0.59
FY 2025	$5.0K	$-4,176,000	$-2.20
Q3 2025	$0	$-1,159,000	$-0.55
Q2 2025	$0	$-1,051,000	$-0.63

Related Market News

No specific coverage for TCRT yet. Check out our latest market news or earnings calendar.

Get TCRT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Alaunos Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.